JP2006160721A - 大脳疲労回復剤 - Google Patents

大脳疲労回復剤 Download PDF

Info

Publication number
JP2006160721A
JP2006160721A JP2005048198A JP2005048198A JP2006160721A JP 2006160721 A JP2006160721 A JP 2006160721A JP 2005048198 A JP2005048198 A JP 2005048198A JP 2005048198 A JP2005048198 A JP 2005048198A JP 2006160721 A JP2006160721 A JP 2006160721A
Authority
JP
Japan
Prior art keywords
fatigue
acid
chlorogenic acids
cerebral
task
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2005048198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006160721A5 (enExample
Inventor
Hidetoshi Sadate
秀敏 左達
Yoshinao Nagashima
義直 永嶋
Takuya Watanabe
卓也 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2005048198A priority Critical patent/JP2006160721A/ja
Priority to PCT/JP2005/020432 priority patent/WO2006051773A1/ja
Priority to US11/718,894 priority patent/US20070270497A1/en
Priority to EP05806145A priority patent/EP1810671A4/en
Priority to KR1020077010085A priority patent/KR20070083944A/ko
Priority to TW094139278A priority patent/TW200621281A/zh
Publication of JP2006160721A publication Critical patent/JP2006160721A/ja
Publication of JP2006160721A5 publication Critical patent/JP2006160721A5/ja
Priority to US12/493,605 priority patent/US20090264524A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2005048198A 2004-11-09 2005-02-24 大脳疲労回復剤 Withdrawn JP2006160721A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2005048198A JP2006160721A (ja) 2004-11-09 2005-02-24 大脳疲労回復剤
PCT/JP2005/020432 WO2006051773A1 (ja) 2004-11-09 2005-11-08 大脳疲労回復剤
US11/718,894 US20070270497A1 (en) 2004-11-09 2005-11-08 Agent For Recovery From Cerebral Fatigue
EP05806145A EP1810671A4 (en) 2004-11-09 2005-11-08 MEANS FOR RECOVERY AFTER ZEREBRALER FATIGUE
KR1020077010085A KR20070083944A (ko) 2004-11-09 2005-11-08 대뇌 피로 회복제
TW094139278A TW200621281A (en) 2004-11-09 2005-11-09 Cerebral fatigue recovery agent
US12/493,605 US20090264524A1 (en) 2004-11-09 2009-06-29 Agent for recovery from cerebral fatigue

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004324516 2004-11-09
JP2005048198A JP2006160721A (ja) 2004-11-09 2005-02-24 大脳疲労回復剤

Publications (2)

Publication Number Publication Date
JP2006160721A true JP2006160721A (ja) 2006-06-22
JP2006160721A5 JP2006160721A5 (enExample) 2008-04-17

Family

ID=36336452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005048198A Withdrawn JP2006160721A (ja) 2004-11-09 2005-02-24 大脳疲労回復剤

Country Status (6)

Country Link
US (2) US20070270497A1 (enExample)
EP (1) EP1810671A4 (enExample)
JP (1) JP2006160721A (enExample)
KR (1) KR20070083944A (enExample)
TW (1) TW200621281A (enExample)
WO (1) WO2006051773A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018039797A (ja) * 2016-09-02 2018-03-15 花王株式会社 脳機能改善剤

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034410B2 (en) 2011-08-22 2015-05-19 Thomas J. Vella Whole green coffee bean products and methods of production and use
TW201733619A (zh) * 2015-12-16 2017-10-01 Suntory Holdings Ltd 肌肽二肽酶阻礙用組成物
CN111758841B (zh) * 2020-08-19 2023-07-28 上海俏贝丽宠物用品有限公司 促进幼犬猫智力发育的组合物、添加剂、保健品及其制备方法
CN115067450A (zh) * 2022-05-24 2022-09-20 广东橘香斋大健康产业股份有限公司 一种营养补充型抗疲劳固体饮料及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916028A (en) * 1972-07-28 1975-10-28 Gen Foods Corp Sweetness inducer
US3924017A (en) * 1972-07-28 1975-12-02 Gen Foods Corp Sweetness inducer
US4145255A (en) * 1977-02-25 1979-03-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method and device for the detection of phenol and related compounds
DE3603576A1 (de) * 1986-02-06 1987-08-13 Code Kaffee Handel Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz
DE3603574C1 (de) * 1986-02-06 1987-07-23 Ergo Forschungsgmbh Verfahren zur Gewinnung von Chlorogensaeure
JPS62277326A (ja) * 1986-05-24 1987-12-02 Zeria Shinyaku Kogyo Kk 脳機能改善剤
US5788971A (en) * 1993-10-21 1998-08-04 Sky. Food Co., Ltd. Active oxygen free radical scavenging agent
US5958417A (en) * 1996-10-24 1999-09-28 Hsu; Chau-Shin Herbal combinations
JP4210364B2 (ja) * 1998-04-22 2009-01-14 花王株式会社 自律神経機能向上剤及び食品
US6458392B1 (en) * 2000-07-12 2002-10-01 Kao Corporation Preventive, alleviative or remedy for hypertension
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
US6991812B2 (en) * 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
JP4077149B2 (ja) * 2000-11-02 2008-04-16 花王株式会社 自律神経機能向上剤
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
ITMI20022389A1 (it) * 2002-11-12 2004-05-13 Nicox Sa Farmaci per le disfunzioni sessuali.
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018039797A (ja) * 2016-09-02 2018-03-15 花王株式会社 脳機能改善剤

Also Published As

Publication number Publication date
US20090264524A1 (en) 2009-10-22
KR20070083944A (ko) 2007-08-24
TW200621281A (en) 2006-07-01
WO2006051773A1 (ja) 2006-05-18
EP1810671A4 (en) 2010-10-13
US20070270497A1 (en) 2007-11-22
EP1810671A1 (en) 2007-07-25

Similar Documents

Publication Publication Date Title
AU2019200802B2 (en) Synergistic dietary supplement compositions for enhancing physical performance
CN109152400A (zh) 除膳食和运动之外改善体重减轻和心脏健康的方法和组合物
Lee A salt substitute with low sodium content from plant aqueous extracts
JP2022051870A (ja) 脳機能改善剤
WO2002089786A1 (en) Compositions for improving mental concentration
US20090264524A1 (en) Agent for recovery from cerebral fatigue
JP5122709B2 (ja) 精神集中向上用組成物
JP2003261444A (ja) 血管内皮機能改善剤
WO2002100393A1 (fr) Compositions destinees a ameliorer les troubles de manque d'attention/d'hyperactivite
JP2007297304A (ja) 大脳疲労回復剤
JP5357372B2 (ja) 皮膚症状改善剤
JP2007297296A (ja) 大脳疲労回復剤
CN103108556A (zh) 绒毛戴星草衍生成分
JP4812240B2 (ja) 血液流動性改善剤
EP3579856B1 (en) Aronia extract for enhancing reaction time and attention
CN101052389A (zh) 大脑疲劳恢复剂
JP7058407B2 (ja) 経口組成物
US10542989B2 (en) Synergistic dietary supplement compositions for enhancing physical performance and energy levels
US20240207339A1 (en) Composition comprising a phytocomplex from pomegranate and its uses
JP2007161703A (ja) 抗疲労作用化合物および持久力増強作用化合物及びそれを含有する飲食品
JP2018104397A (ja) 抗精神疲労剤、該抗精神疲労剤を用いた食品（健康補助食品）、苦味料、並びにそれらの製造方法
JP5039305B2 (ja) 予防的抗ストレス剤
Crossland The effects of cannabidiol on measures of performance following eccentric exercise
JP2017519814A (ja) 集中力を向上するための方法および組成物
JP2005187344A (ja) 大脳疲労の回復剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080221

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080222

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20110617